Sho Isogai
- Physiology top 10%
- Pulmonary and Respiratory Medicine
- Molecular Biology
- Nephrology top 5%
- Cancer Research
- Co-authors
- Makoto HoshinoYutaka NakamuraHayato TadaGen YoshinoYasuo OshimaKenji OheKoji KubokiToshiko Takao
- Topics
- Chronic Kidney Disease and Diabetes (5 papers)Advanced Glycation End Products research (5 papers)Protease and Inhibitor Mechanisms (3 papers)
In The Last Decade
Sho Isogai
23 papers receiving 539 citations
Peers
Comparison fields: 5 of 66
- Physiology 216
- Pulmonary and Respiratory Medicine 153
- Molecular Biology 113
- Nephrology 88
- Cancer Research 72
Countries citing papers authored by Sho Isogai
This map shows the geographic impact of Sho Isogai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sho Isogai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sho Isogai more than expected).
Fields of papers citing papers by Sho Isogai
This network shows the impact of papers produced by Sho Isogai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sho Isogai. The network helps show where Sho Isogai may publish in the future.
Co-authorship network of co-authors of Sho Isogai
This figure shows the co-authorship network connecting the top 25 collaborators of Sho Isogai. A scholar is included among the top collaborators of Sho Isogai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sho Isogai. Sho Isogai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 19 | |
| 3 | 249 | |
| 4 | 33 | |
| 5 | 15 | |
| 6 | 62 | |
| 7 | 33 | |
| 8 | 13 | |
| 9 | 10 | |
| 10 | Clinical effect of the anti-platelet drug, dilazep dihydrochloride, in patients at the microalbuminuric stage of diabetic nephropathy--a multi-center study. | 7 |
| 11 | 16 | |
| 12 | 20 | |
| 13 | 7 | |
| 14 | 16 | |
| 15 | 6 | |
| 16 | 3 | |
| 17 | 10 | |
| 18 | 7 | |
| 19 | 3 | |
| 20 | 3 |
About Sho Isogai
Sho Isogai is a scholar working on Clinical Biochemistry, Nephrology and Endocrinology, Diabetes and Metabolism, having authored 24 papers that have together received 551 indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (5 papers), Advanced Glycation End Products research (5 papers) and Protease and Inhibitor Mechanisms (3 papers). The work is most often cited by research in Nephrology (88 citations), Clinical Biochemistry (69 citations) and Physiology (216 citations). Sho Isogai has collaborated with scholars based in Japan and China. Frequent co-authors include Makoto Hoshino, Yutaka Nakamura, Hayato Tada, Gen Yoshino, Yasuo Oshima, Kenji Ohe, Koji Kuboki, Toshiko Takao, Tsutomu Urayama and Y. Totsuka. Their work appears in journals such as Journal of Allergy and Clinical Immunology, Diabetologia and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.